199 related articles for article (PubMed ID: 8134105)
1. Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance.
Hu N; Gutsmann A; Herbert DC; Bradley A; Lee WH; Lee EY
Oncogene; 1994 Apr; 9(4):1021-7. PubMed ID: 8134105
[TBL] [Abstract][Full Text] [Related]
2. ARF mutation accelerates pituitary tumor development in Rb+/- mice.
Tsai KY; MacPherson D; Rubinson DA; Nikitin AY; Bronson R; Mercer KL; Crowley D; Jacks T
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16865-70. PubMed ID: 12486224
[TBL] [Abstract][Full Text] [Related]
3. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin.
Harvey M; Vogel H; Lee EY; Bradley A; Donehower LA
Cancer Res; 1995 Mar; 55(5):1146-51. PubMed ID: 7867001
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility to tumors induced in mice by ethylnitrosourea is independent of retinoblastoma gene dosage.
Riley DJ; Lai CC; Chang CY; Jones D; Lee EY; Lee WH
Cancer Res; 1994 Dec; 54(23):6097-101. PubMed ID: 7954454
[TBL] [Abstract][Full Text] [Related]
5. Proopiomelanocortin heterozygous and homozygous null mutant mice develop pituitary adenomas.
Karpac J; Ostwald D; Li GY; Bui S; Hunnewell P; Brennan MB; Hochgeschwender U
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(2):47-52. PubMed ID: 16914086
[TBL] [Abstract][Full Text] [Related]
6. A dynamic switch in Rb+/- mediated neuroendocrine tumorigenesis.
Leung SW; Wloga EH; Castro AF; Nguyen T; Bronson RT; Yamasaki L
Oncogene; 2004 Apr; 23(19):3296-307. PubMed ID: 15021915
[TBL] [Abstract][Full Text] [Related]
7. Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells.
Vooijs M; te Riele H; van der Valk M; Berns A
Oncogene; 2002 Jul; 21(30):4635-45. PubMed ID: 12096340
[TBL] [Abstract][Full Text] [Related]
8. Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse.
Vooijs M; van der Valk M; te Riele H; Berns A
Oncogene; 1998 Jul; 17(1):1-12. PubMed ID: 9671308
[TBL] [Abstract][Full Text] [Related]
9. Suppression of melanotroph carcinogenesis leads to accelerated progression of pituitary anterior lobe tumors and medullary thyroid carcinomas in Rb+/- mice.
Zhou Z; Flesken-Nikitin A; Levine CG; Shmidt EN; Eng JP; Nikitina EY; Spencer DM; Nikitin AY
Cancer Res; 2005 Feb; 65(3):787-96. PubMed ID: 15705875
[TBL] [Abstract][Full Text] [Related]
10. Cell lineage-specific effects associated with multiple deficiencies of tumor susceptibility genes in Msh2(-/-)Rb(+/-) mice.
Nikitin AY; Liu CY; Flesken-Nikitin A; Chen CF; Chen PL; Lee WH
Cancer Res; 2002 Sep; 62(18):5134-8. PubMed ID: 12234974
[TBL] [Abstract][Full Text] [Related]
11. Effects of an Rb mutation in the mouse.
Jacks T; Fazeli A; Schmitt EM; Bronson RT; Goodell MA; Weinberg RA
Nature; 1992 Sep; 359(6393):295-300. PubMed ID: 1406933
[TBL] [Abstract][Full Text] [Related]
12. Effects of heterozygosity for the Rb-1t19neo allele in the mouse.
Harrison DJ; Hooper ML; Armstrong JF; Clarke AR
Oncogene; 1995 Apr; 10(8):1615-20. PubMed ID: 7731716
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the retinoblastoma tumor suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis.
Guo Z; Yikang S; Yoshida H; Mak TW; Zacksenhaus E
Cancer Res; 2001 Dec; 61(23):8395-400. PubMed ID: 11731416
[TBL] [Abstract][Full Text] [Related]
14. Developmental defects and tumor predisposition in Rb mutant mice.
Vooijs M; Berns A
Oncogene; 1999 Sep; 18(38):5293-303. PubMed ID: 10498881
[TBL] [Abstract][Full Text] [Related]
15. Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas.
Simpson DJ; Magnay J; Bicknell JE; Barkan AL; McNicol AM; Clayton RN; Farrell WE
Cancer Res; 1999 Apr; 59(7):1562-6. PubMed ID: 10197629
[TBL] [Abstract][Full Text] [Related]
16. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB.
Pei L; Melmed S; Scheithauer B; Kovacs K; Benedict WF; Prager D
Cancer Res; 1995 Apr; 55(8):1613-6. PubMed ID: 7712461
[TBL] [Abstract][Full Text] [Related]
17. Partial inactivation of the RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors.
Kratzke RA; Otterson GA; Hogg A; Coxon AB; Geradts J; Cowell JK; Kaye FJ
Oncogene; 1994 May; 9(5):1321-6. PubMed ID: 8152792
[TBL] [Abstract][Full Text] [Related]
18. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.
Dodson MK; Cliby WA; Xu HJ; DeLacey KA; Hu SX; Keeney GL; Li J; Podratz KC; Jenkins RB; Benedict WF
Cancer Res; 1994 Feb; 54(3):610-3. PubMed ID: 8306318
[TBL] [Abstract][Full Text] [Related]
19. Earlier onset of melanotroph carcinogenesis in mice with inherited mutant paternal allele of the retinoblastoma gene.
Nikitin AY; Riley DJ; Lee WH
Cancer Res; 1997 Oct; 57(19):4274-8. PubMed ID: 9331088
[TBL] [Abstract][Full Text] [Related]
20. Switching of melanocyte pigmentation associated with pituitary pars intermedia tumors in Rb+/- and p27-/- female mice with yellow pelage.
Smith AP; Henze M; Osborn KG; Lee JA; Bortner DM; Rosenberg MP; Reed SI
Comp Med; 2003 Feb; 53(1):75-80. PubMed ID: 12625510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
